Shares outstanding increased 55.7%
Shares outstanding changed +55.7% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +55.7% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
Stock-based compensation changed +43.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +17.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating income changed +17.4% from the comparable as-filed period.
Operating cash flow changed +18.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed -26.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -23.5% from the comparable as-filed period.
Working capital changed +22.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current assets changed +20.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.